Evidence map›Paper›PMID 35215131›Full record

ArticlePathogens (Basel, Switzerland)2022

Sheltered in Stromal Tissue Cells,

Lucas Vellasco, Erik Svensjö, Carlos Alberto Bulant, Pablo Javier Blanco, Fábio Nogueira, Gilberto Domont, Natália Pinto de Almeida, Clarissa Rodrigues Nascimento, Danielle Silva-Dos-Santos, Carla Eponina Carvalho-Pinto and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Host angiogenic reprogramming byFrontiers in microbiology · 2025
    Article
  2. The 50th Anniversary Conference - Caxambu 2024.Memorias do Instituto Oswaldo Cruz · 2025
    Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lucas VellascoDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Erik SvensjöDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0002-7356-1787
Carlos Alberto BulantDepartment of Mathematical and Computational Methods, National Laboratory for Scientific Computing, Petrópolis 25651-075, Brazil.ORCID 0000-0003-0911-7849
Pablo Javier BlancoDepartment of Mathematical and Computational Methods, National Laboratory for Scientific Computing, Petrópolis 25651-075, Brazil.ORCID 0000-0003-3527-619X
Fábio NogueiraDepartment of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0001-5507-7142
Gilberto DomontDepartment of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
Natália Pinto de AlmeidaDepartment of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
Clarissa Rodrigues NascimentoDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Danielle Silva-Dos-SantosDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Carla Eponina Carvalho-PintoDepartment of Immunobiology, Institute of Biology, Federal Fluminense University, Niterói 24210-201, Brazil.
Emiliano Horácio MedeiDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Igor C AlmeidaDepartment of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.
Julio ScharfsteinDepartment of Immunobiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Universidade Federal do Rio de Janeiro · BRLaboratório Nacional de Computação Científica · BRThe University of Texas at El Paso · USUniversidade Federal Fluminense · BR

Funding

Argentinian funding agency ANPCyT PICT-2018-02427Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 440613/2016-7Coordernação de Aperfeiçoamento de Pessoal em Nível Superior (CAPES) 88887.130697Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) 2014/50889-7Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) 2018/14221-2Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro 250684 - Projeto temáticoFundação de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/202.650/2018Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.173/2018Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro PRONEX - 209436National Institute on Minority Health and Health Disparities (NIMHD) 5U54MD007592
6 · The paper itself

Abstract

Microangiopathy may worsen the clinical outcome of Chagas disease. Given the obstacles to investigating the dynamics of inflammation and angiogenesis in heart tissues parasitized by

Indexed as

angiogenesischymaseinflammationmast cellTrypanosoma cruzi

Identifiers

PMID35215131
PMCPMC8878313
OpenAlexW4210736657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.